Cargando…

Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial

BACKGROUND: Ankylosing spondylitis (AS) is a chronic inflammatory autoimmune disease. Kunxian capsule, a Chinese patent medicine which has been used in the treatment of immunologic diseases for many years in China, has anti-inflammatory and immunoregulatory effects. This study investigates the effic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qiuxia, Li, Li, Bi, Liqi, Xiao, Changhong, Lin, Zhiming, Cao, Shuangyan, Liao, Zetao, Gu, Jieruo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957347/ https://www.ncbi.nlm.nih.gov/pubmed/27449221 http://dx.doi.org/10.1186/s13063-016-1438-6

Ejemplares similares

Complex Segregation Analysis Provides Evidence for Autosomal Dominant Transmission in the Chinese Han Families with Ankylosing Spondylitis
por: Jiang, Yutong, et al.
Publicado: (2017)

Clinical Features in Juvenile-Onset Ankylosing Spondylitis Patients Carrying Different B27 Subtypes
por: Mou, Yikun, et al.
Publicado: (2015)

Serum Vitamin D and Pyridinoline Cross-Linked Carboxyterminal Telopeptide of Type I Collagen in Patients with Ankylosing Spondylitis
por: Zhang, Pingping, et al.
Publicado: (2015)

Disorders of MicroRNAs in Peripheral Blood Mononuclear Cells: As Novel Biomarkers of Ankylosing Spondylitis and Provocative Therapeutic Targets
por: Lv, Qing, et al.
Publicado: (2015)

Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China
por: Tu, Liudan, et al.
Publicado: (2020)

Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study
por: Wu, Jialing, et al.
Publicado: (2020)

Etanercept/celecoxib on improving MRI inflammation of active ankylosing spondylitis: A multicenter, open-label, randomized clinical trial
por: Tu, Liudan, et al.
Publicado: (2022)

A Rare Co-Segregation-Mutation in the Insulin Receptor Substrate 1 Gene in One Chinese Family with Ankylosing Spondylitis
por: Rong, Ju, et al.
Publicado: (2015)

Immunogenetic Study in Chinese Population with Ankylosing Spondylitis: Are There Specific Genes Recently Disclosed?
por: Zhai, Jiayu, et al.
Publicado: (2013)

Serum from patients with ankylosing spondylitis can increase PPARD, fra-1, MMP7, OPG and RANKL expression in MG63 cells
por: Hu, Zaiying, et al.
Publicado: (2015)

A Genome-Wide SNP Linkage Analysis Suggests a Susceptibility Locus on 6p21 for Ankylosing Spondylitis and Inflammatory Back Pain Trait
por: Zhang, Yanli, et al.
Publicado: (2016)

Serum Metabolomics Signatures Associated With Ankylosing Spondylitis and TNF Inhibitor Therapy
por: Ou, Jiayong, et al.
Publicado: (2021)

Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients
por: Lin, Zhiming, et al.
Publicado: (2009)

Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with ankylosing spondylitis: A 4-week randomized, open-label study
por: Fan, Meida, et al.
Publicado: (2019)

Integrative blood-derived epigenetic and transcriptomic analysis reveals the potential regulatory role of DNA methylation in ankylosing spondylitis
por: Xiao, Min, et al.
Publicado: (2022)

Effectiveness and safety of KunXian capsule for the treatment of IgA nephropathy
por: Le, Wei-Bo, et al.
Publicado: (2022)

The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients
por: Wu, Xinyu, et al.
Publicado: (2021)

Pain- and Fatigue-Related Functional and Structural Changes in Ankylosing Spondylitis: An fRMI Study
por: Liu, Qi, et al.
Publicado: (2020)

Network Pharmacology-Based Analysis on the Curative Effect of Kunxian Capsules against Rheumatoid Arthritis
por: Yan, Hong-Xia, et al.
Publicado: (2021)

Dynamics of Adaptive Immune Cell and NK Cell Subsets in Patients With Ankylosing Spondylitis After IL-17A Inhibition by Secukinumab
por: Jiang, Yutong, et al.
Publicado: (2021)

Pharmacological importance of Kunxian Capsule in clinical applications and its adverse effects: A review
por: Ma, Ruijiao, et al.
Publicado: (2023)

Editorial: Advances in Pathogenesis, Etiology, and Therapies for Ankylosing Spondylitis
por: Chen, Chih-Wei, et al.
Publicado: (2021)

Kunxian Capsule for Rheumatoid Arthritis: Inhibition of Inflammatory Network and Reducing Adverse Reactions Through Drug Matching
por: Tang, Yujun, et al.
Publicado: (2020)

Indirect comparison of NSAIDs for ankylosing spondylitis: Network meta-analysis of randomized, double-blinded, controlled trials
por: Fan, Meida, et al.
Publicado: (2020)

Kunxian capsule alleviates podocyte injury and proteinuria by inactivating β-catenin in db/db mice
por: Jin, Bo, et al.
Publicado: (2023)

Exploring the causality between ankylosing spondylitis and atrial fibrillation: A two-sample Mendelian randomization study
por: Chen, Shuhong, et al.
Publicado: (2022)

Imbalance of Peripheral Lymphocyte Subsets in Patients With Ankylosing Spondylitis: A Meta-Analysis
por: Liu, Dong, et al.
Publicado: (2021)

Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis
por: Chen, Zena, et al.
Publicado: (2021)

TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis
por: Yang, Mingcan, et al.
Publicado: (2020)

The Derivative of Tripterygium wilfordii Hook F—Kunxian Capsule, Attenuated Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Liu, Ya-Fei, et al.
Publicado: (2020)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)

Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)

Osteogenic differentiation characteristics of hip joint capsule fibroblasts obtained from patients with ankylosing spondylitis
por: Jiang, Nan, et al.
Publicado: (2021)

MiR-27a Targets sFRP1 in hFOB Cells to Regulate Proliferation, Apoptosis and Differentiation
por: Guo, Donggeng, et al.
Publicado: (2014)

Ankylosing spondylitis: etiology, pathogenesis, and treatments
por: Zhu, Wei, et al.
Publicado: (2019)

Cytokines and regulatory T cells in ankylosing spondylitis
por: Liao, Hsien-Tzung, et al.
Publicado: (2023)

Mechanism of Xinfeng Capsule in the Treatment of Hypercoagulable State of Ankylosing Spondylitis Based on Data Mining and Network Pharmacology
por: Li, Xu, et al.
Publicado: (2022)

Spondyloarthritis Patients Suffer Increased Risk of Renal Complications Compared With General Population: A Retrospective Observational Study
por: Xiao, Min, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fu7l3p5qsu51q69k0b6p38ou3l